M3 stock initiated with Overweight rating by JPMorgan on growth outlook

Published 07/07/2025, 15:32
M3 stock initiated with Overweight rating by JPMorgan on growth outlook

Investing.com - JPMorgan has initiated coverage on M3, Inc (TYO:2413) (OTC:MTHRF) with an Overweight rating and a price target of JPY2,300.00 through December 2026.

The Japanese healthcare platform’s share price has remained weak over the past three years due to declining COVID-19-related special demand, according to JPMorgan’s analysis.

The investment bank expects M3’s profit growth to resume from fiscal year 2025, with valuations likely to increase further as the company navigates current market conditions.

While pharmaceutical companies are reducing their medical representative budgets in M3’s core marketing support business, JPMorgan notes this headwind is balanced by increasing digital transformation in sales and marketing operations, which should support moderate medium to long-term sales growth.

JPMorgan also highlights potential strong growth in M3’s overseas operations, particularly in the U.S. clinical trial business, which has completed organizational reforms after experiencing weakness until fiscal year 2013.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.